Is Pfizer Stock Still a Buy After an Unexpected Setback?
Is the rebound fading? Goldman Sachs: Hedge funds are selling stocks at the fastest pace in more than two years.
In August, 'smart money' is selling global equities at the fastest pace since March 2022, with the most net selling in North America. Hedge funds are skeptical of the sustainability of the stock market rebound, and geopolitical concerns continue to be worrying. The 'fly' of the economic situation may soon hit the glass windshield.
Pfizer Options Spot-On: On August 23rd, 131.25K Contracts Were Traded, With 2.86 Million Open Interest
5 Things You Need to Know About COVID, Flu and RSV Vaccines This Fall
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
The FDA Approved a New Covid Vaccine. Should You Get It? -- Update 2 -- WSJ
